Retargeting has been achieved through the conjugation of antibodies directed against CD59, CD71, transferrin, EGFR [278] or cholera toxin B to fiber-modified BAP vectors, resulting in enhanced infection in CAR-negative carcinoma cell lines [222]. This evidence concerns the gene EGFR and carcinoma.